Oncoproteins and tumor suppressor proteins in congenital sacrococcygeal teratomas

Pediatric Pathology and Laboratory Medicine

Volumn 17, Issue 1, 1997, Pages 43-52

  Kruslin, Bozo ^a,b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

oncogenes; p53; ras; sacrococcygeal teratoma; tumor suppressor genes

Indexed keywords

ONCOPROTEIN; PROTEIN P53;

ARTICLE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INFANT; MALE; NEWBORN; ONCOGENE; ONCOGENE C FOS; ONCOGENE C JUN; ONCOGENE RAS; PRIORITY JOURNAL; SACROCOCCYX TERATOMA; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

EID: 0031022161     PISSN: 10771042     EISSN: None     Source Type: Journal    
DOI: 10.1080/107710497175010     Document Type: Article

References (20)

1. Berry CL, Keeling J, Hilton C. Teratomata in infancy and childhood: A review of 91 cases. J Pathol 1969;98:241-52.
2. Altman RP, RandolphJG, Lilly JR. Sacrococcygeal teratoma: American Academy of Pediatrics, Surgical Section Survey-1973. J Pediatr Surg 1974:9:389-98.
3. Valdiserri RO, Yunis E). Sacrococcygeal teratomas: A review of 68 cases. Cancer 1981 ;48:217-21.
4. Dehner LP. Gonadal and extragonadal germ cell neoplasia of childhood. Hum Pathol 1983; 14: 493-511.
5. Lahdenne P, Heikinheimo M, Nikkanen V, Klemi P, Sûmes MA, RapolaJ. Neonatal benign Sacrococcygeal teratoma may recur in adulthood and give rise to malignancy. Cancer 1993:72:3727-31.
6. Bishop JM. Molecular themes in oncogenesis. Cell 1991;64:235-48.
7. Lee W-H, Shew J-Y, Sery TW, Donoso LA, Young L-Y, Lee E-Y. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 1987; 329:642-5.
8. PorembaC, Dockhorn-DworniczakB, MerritlV, etal. Immature teratomas of different origin carried by a pregnant mother and her fetus. Diagn Mol Pathol 1993:2:131-6.
9. Norris HJ, Zirkin HJ, Benson WL. Immature (malignant) teratoma of the ovary, a clinical and pathological study of 58 cases. Cancer 1976;37:2359-72.
10. Paveli
11. PaveW J, Gall-Troselj K, Hlavka V, et al. nm23-H-1 protein in oligodendrogliomas. Int J Oncol 1994:4:161-4.
12. PaveW K, Hrascan R, Kapitanovid S, et al. Multiple genetic alterations in malignant metastatic insulinomas.J Pathol 1995; 177:395-400.
13. Poljak LJ, Pefina N, Dzubur A, Uzarevic' B, Vitale B, Pavelié K. Modulauon of p62 c-myc expression in a single case of non-T acute lymphoblastic leukemia (ALL) assessed by image analyzer. Tumordiagn Ther 1993;14:158-62.
14. Cannon JV, Greaves R, Iggo R, Lane DP. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBOJ 1990;9:1595-602.
15. Manojlovié S, Cviko A, Vlatković LJ. Sacrococcygeal teratomas in autopsy and bioptic material. Libri Oncol 1987:16:187-94.
16. PavelieJ, Hlavka V, Poljak M, Gale N, PaveW K. p53 immunoreactivity in oligodendrogliomas. J Neurooncol 1994;22:l-6.
17. Fearon E, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
18. Shuin T, Misaki H, Kubota Y, Yao M, Hosaka M. Differential expression of protooncogenes in human germ cell tumors of the testis. Cancer 1994;73:1721-7.
19. Strohmeyer TG, Slamon DJ. Proto-oncogenes and tumor suppressor genes in human urological malignancies. J Urol 1994;151:1479-97.
20. Murty W, Bosl GJ, Houldsworth J, et al. Allelic loss and somatic differentiation in human male germ cell tumors. Oncogene 1994;9:2245-51.